— Know what they know.
Not Investment Advice
Also trades as: FFLWF (OTC) · $vol 0M

FAF.TO TSX

Fire & Flower Holdings Corp.
1W: -27.5% 1M: -78.5% 3M: -76.4% 1Y: -92.1% 3Y: -95.9%
C$0.29
Last traded 2023-06-05 — delisted
TSX · Healthcare · Medical - Pharmaceuticals · C$13.1M mcap · 28M float · 0.477% daily turnover
#? of ?
Medical - Pharmaceuticals
Healthcare · Micro Cap · 12 peers
Market Share
0.0%
Top 4 Concentration: 0.0%

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
FAF.TO Fire & Flower Holdings Corp. $10M -0.1 -80.0 -26.4 -23.4 -3.9 2 N/A -92.1
EBM.V Eastwood Bio-Medical Canada Inc. $130M -645.2 13.9 12.4 -45.1 36.6 6 BULLISH 380.5
CSCI.TO COSCIENS Biopharma Inc. $10M — — — — — — BULLISH —
RX.V BioSyent Inc. $190M 19.0 23.7 23.8 14.3 40.9 4 BULLISH 41.1
HITI High Tide Inc. $330M -9.9 -26.9 1.6 5.7 27.2 3 BULLISH -27.1
INNO.CN InnoCan Pharma Corporation $10M -7.4 -20.9 -13549.9 -0.6 -18.6 3 LEAN BEAR -84.6
CYBN.NE Cybin Inc. $410M -2.8 -62.5 -156.6 — — 2 LEAN BEAR 73.8
PKBFF PeakBirch Commerce Inc. $540M -0.0 -16609.0 16544.6 -58.8 -69.1 3 BEARISH 0.0
MDP.TO Medexus Pharmaceuticals Inc. $160M -43.4 -4.7 6.8 -10.9 -8.3 5 BEARISH 67.0
GSD.V Devonian Health Group, Inc. $20M — — — — — — BEARISH —
HELP Cybin Inc. Common Stock $740M -2.8 -38.6 -94.5 — — 2 BEARISH —
MYCOF Noveris Health Sciences Inc. $40M -6.6 22.3 49.3 — — 5 BEARISH 12066.7
LSL.V LSL Pharma Group Inc $40M — — — — — — BEARISH —

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

FAF.TO vs Benchmarks

ROIC
FAF.TO
-26.4
Industry
7.4
Gross Margin
FAF.TO
28.9
Industry
47.5
Op Margin
FAF.TO
-15.3
Industry
-9.0
Net Margin
FAF.TO
-23.4
Industry
-7.9
Sector
-157.4
Revenue Growth
FAF.TO
-3.9
Sector
0.8
P/E Ratio
FAF.TO
-0.1
Sector
17.0
ROE
FAF.TO
-80.0
Sector
-70.3
Piotroski F
FAF.TO
2.0
Sector
3.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms